Beyond The Printed Page

  1. Biopharma Parallel — Women Bring Balance
    4/17/2019

    Rachel King, CEO and cofounder of GlycoMimetics, talks about women in the biopharma industry as part of this preview of her feature story that appears in the May issue of LSL.

  2. Alkermes’ Richard Pops On Always Looking Forward
    4/15/2019

    Richard Pops, CEO of Alkermes, discusses his philosophy of being forward looking, but shares how such an approach can also have its drawbacks.

  3. The Keys To Success For ViiV Healthcare
    3/25/2019

    Deborah Waterhouse, CEO of ViiV Healthcare, provides insight as to how GSK’s joint venture has been able to achieve and maintain success.

  4. A Pharma Exec Defines Her “Recipe for Business Success”
    3/18/2019

    Deborah Waterhouse, CEO of GSK’s joint venture ViiV Healthcare, discusses her three keys to business success.

  5. A CEO’s Most Formative Leadership Experience
    2/25/2019

    Intellia Therapeutics CEO, John Leonard, M.D., shares a formative leadership experience from his days at Abbott Laboratories. 

  6. What You Don’t Know About John Leonard, The CEO Of Intellia Therapeutics
    2/19/2019

    Intellia Therapeutics CEO, John Leonard, M.D., provides insight into why he entered industry, and his drive to be an entrepreneur. 

  7. Making A Difference Matters
    12/17/2018

    Dr. Helen Torley, president and CEO of Halozyme Therapeutics, shares a story of how the biopharmaceutical industry makes a difference.

  8. Helen Torley’s Path To The C-Suite
    12/12/2018

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her path to the c-suite, including the formative experience that best prepared her for becoming a CEO.

  9. Could Halozyme’s U.S. Patent 8,846,034 Be Another Royalty Boon?
    12/10/2018

    Helen Torley, president and CEO of Halozyme Therapeutics, discusses hyaluronan and the role it plays in development of ENHANZE, PEGPH20 along with a staining diagnostic to determine patients with high levels of hyaluronic acid (HA).

  10. Insight For First-Time CEOs Presenting At JPM
    12/4/2018

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her approach to preparing and presenting as a first-time CEO at the annual J.P. Morgan Healthcare Conference.